about
Increased adverse drug reactions to antimicrobials and anticonvulsants in patients with HIV infection.Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study.Clinically relevant drug interactions with antiepileptic drugsDrug interactions in the management of HIV infection.Altered cytochrome p450 metabolism of calcineurin inhibitors: case report and review of the literature.The impact of enzyme-inducing antiepileptic drugs on antiretroviral drug levels: a case-control study.Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors.Drug interactions in the management of HIV infection: an update.Safe Treatment of Seizures in the Setting of HIV/AIDS.Role of anticonvulsants in the management of AIDS related seizures.Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients.Seizure management in a complex hospice patient.Possible antiretroviral therapy-warfarin drug interaction.Prevalence of seizures in children infected with human immunodeficiency virus.Neurologic and neurobehavioral sequelae in children with human immunodeficiency virus (HIV-1) infection.Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjects.Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject.Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir.
P2860
Q33254111-7282B1A8-06A0-4C44-A0E5-76838C2E977CQ33610934-E6335180-2D06-4D97-A4E9-F971C6A0D82BQ35057326-090C9D66-0BBE-4950-8265-7171E5A277ABQ35827491-1151101B-8573-4118-A96E-130F47BA91C8Q36066083-22118968-4F3A-4A17-A29F-4DF1DED1C274Q36188339-6F204D15-8768-479A-9720-BC187A9746BFQ36428784-217D670C-BD68-415E-93CB-FB4919961F26Q36544977-7A6BEEA6-01B0-4042-A7A9-71D441C26E8CQ37000733-A6054CC3-CBD3-416D-AF18-14673CC3D647Q37096562-3587B6CA-1A89-482C-84F0-68AE4EE4CDD7Q37531331-F219A8CD-5AA7-434A-9E40-01209AD39507Q37845854-2ADD866A-18F1-4A14-A073-A8954530007CQ43117585-8B09D505-BD5D-491D-B462-7248D2919514Q43977905-17B63AEB-42D9-43FC-BEBE-A8C9BA79D162Q45356453-2BBCC645-DA9D-45C5-96D5-80B5BB7BF600Q45366217-1DF20DC2-AC72-44AE-BD0A-1972BA69B1BDQ46562540-B5094FBF-9F39-4BE5-805F-2CC7A6E3414AQ46812234-EA32CBA1-744E-45B4-B404-BFFB6EA8C48CQ48499508-EBEF395B-450C-4816-A763-F2733834F50A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Anticonvulsant and antiretroviral interactions.
@ast
Anticonvulsant and antiretroviral interactions.
@en
type
label
Anticonvulsant and antiretroviral interactions.
@ast
Anticonvulsant and antiretroviral interactions.
@en
prefLabel
Anticonvulsant and antiretroviral interactions.
@ast
Anticonvulsant and antiretroviral interactions.
@en
P2093
P2860
P356
P1476
Anticonvulsant and antiretroviral interactions.
@en
P2093
Michelle D Liedtke
R Chris Rathbun
Staci M Lockhart
P2860
P304
P356
10.1345/APH.1D309
P407
P577
2004-01-23T00:00:00Z